199 related articles for article (PubMed ID: 23812072)
21. Gene Therapy for the Treatment of Primary Immune Deficiencies.
Kuo CY; Kohn DB
Curr Allergy Asthma Rep; 2016 May; 16(5):39. PubMed ID: 27056559
[TBL] [Abstract][Full Text] [Related]
22. Gene therapy for primary immunodeficiencies: current status and future prospects.
Qasim W; Gennery AR
Drugs; 2014 Jun; 74(9):963-9. PubMed ID: 24848753
[TBL] [Abstract][Full Text] [Related]
23. Hematopoietic stem cell transplantation for primary immunodeficiency diseases.
Slatter MA; Cant AJ
Ann N Y Acad Sci; 2011 Nov; 1238():122-31. PubMed ID: 22129059
[TBL] [Abstract][Full Text] [Related]
24. Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Patients in the Black Sea Region of Turkey.
Yıldıran A; Çeliksoy MH; Borte S; Güner ŞN; Elli M; Fışgın T; Özyürek E; Sancak R; Oğur G
Turk J Haematol; 2017 Dec; 34(4):345-349. PubMed ID: 28404538
[TBL] [Abstract][Full Text] [Related]
25. What is the status of gene therapy for primary immunodeficiency?
Blaese RM
Immunol Res; 2007; 38(1-3):274-84. PubMed ID: 17917032
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry.
Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw P; Teague L; Fraser C; Carter T; Tapp H; Alvaro F; O'Brien TA
Biol Blood Marrow Transplant; 2013 Mar; 19(3):338-43. PubMed ID: 23228588
[TBL] [Abstract][Full Text] [Related]
27. [Clinical study on cytomegalovirus infection after hematopoietic stem cell transplantation in 26 patients with primary immunodeficiency diseases].
Que M; Xiao J; Guan X; Xian Y; Su Y; Wen X; Li Y; Wang Y; Xiao L; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):424-7. PubMed ID: 24857213
[TBL] [Abstract][Full Text] [Related]
28. [Gene therapy for primary immunodeficiency diseases].
Ariga T
Nihon Rinsho; 2005 Dec; 63 Suppl 12():641-5. PubMed ID: 16416867
[No Abstract] [Full Text] [Related]
29. Advances in hematopoietic stem cell transplantation for primary immunodeficiency.
Gennery AR; Cant AJ
Immunol Allergy Clin North Am; 2008 May; 28(2):439-56, x-xi. PubMed ID: 18424341
[TBL] [Abstract][Full Text] [Related]
30. Good Laboratory Practice Preclinical Safety Studies for GSK2696273 (MLV Vector-Based Ex Vivo Gene Therapy for Adenosine Deaminase Deficiency Severe Combined Immunodeficiency) in NSG Mice.
Carriglio N; Klapwijk J; Hernandez RJ; Vezzoli M; Chanut F; Lowe R; Draghici E; Nord M; Albertini P; Cristofori P; Richards J; Staton H; Appleby J; Aiuti A; Sauer AV
Hum Gene Ther Clin Dev; 2017 Mar; 28(1):17-27. PubMed ID: 28319446
[TBL] [Abstract][Full Text] [Related]
31. Progress in primary immunodeficiency.
Matsumoto S; Sakiyama Y; Ariga T; Gallagher R; Taguchi Y
Immunol Today; 1992 Jan; 13(1):4-5. PubMed ID: 1739431
[TBL] [Abstract][Full Text] [Related]
32. Update on gene therapy for immunodeficiencies.
Kohn DB
Clin Immunol; 2010 May; 135(2):247-54. PubMed ID: 20071242
[TBL] [Abstract][Full Text] [Related]
33. Stem cell transplantation in primary immunodeficiency disease patients.
Sato T; Kobayashi R; Toita N; Kaneda M; Hatano N; Iguchi A; Kawamura N; Ariga T
Pediatr Int; 2007 Dec; 49(6):795-800. PubMed ID: 18045274
[TBL] [Abstract][Full Text] [Related]
34. [Gene and cell therapy for primary immunodeficiency diseases].
Otsu M
Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(6):312-6. PubMed ID: 21212583
[TBL] [Abstract][Full Text] [Related]
35. The Phenotype and Treatment of WIP Deficiency: Literature Synopsis and Review of a Patient With Pre-transplant Serial Donor Lymphocyte Infusions to Eliminate CMV.
Schwinger W; Urban C; Ulreich R; Sperl D; Karastaneva A; Strenger V; Lackner H; Boztug K; Albert MH; Benesch M; Seidel MG
Front Immunol; 2018; 9():2554. PubMed ID: 30450104
[TBL] [Abstract][Full Text] [Related]
36. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
Hacein-Bey Abina S; Gaspar HB; Blondeau J; Caccavelli L; Charrier S; Buckland K; Picard C; Six E; Himoudi N; Gilmour K; McNicol AM; Hara H; Xu-Bayford J; Rivat C; Touzot F; Mavilio F; Lim A; Treluyer JM; Héritier S; Lefrère F; Magalon J; Pengue-Koyi I; Honnet G; Blanche S; Sherman EA; Male F; Berry C; Malani N; Bushman FD; Fischer A; Thrasher AJ; Galy A; Cavazzana M
JAMA; 2015 Apr; 313(15):1550-63. PubMed ID: 25898053
[TBL] [Abstract][Full Text] [Related]
37. Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.
Otsu M; Yamada M; Nakajima S; Kida M; Maeyama Y; Hatano N; Toita N; Takezaki S; Okura Y; Kobayashi R; Matsumoto Y; Tatsuzawa O; Tsuchida F; Kato S; Kitagawa M; Mineno J; Hershfield MS; Bali P; Candotti F; Onodera M; Kawamura N; Sakiyama Y; Ariga T
J Clin Immunol; 2015 May; 35(4):384-98. PubMed ID: 25875699
[TBL] [Abstract][Full Text] [Related]
38. [Bone marrow transplantation in the primary immunodeficiencies].
Madero López L; Villa Alcázar M
Sangre (Barc); 1999 Apr; 44(2):135-41. PubMed ID: 10382323
[No Abstract] [Full Text] [Related]
39. In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency.
Selleri S; Brigida I; Casiraghi M; Scaramuzza S; Cappelli B; Cassani B; Ferrua F; Aker M; Slavin S; Scarselli A; Cancrini C; Marktel S; Grazia Roncarolo M; Aiuti A
J Allergy Clin Immunol; 2011 Jun; 127(6):1368-75.e8. PubMed ID: 21477850
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy for primary immunodeficiencies: Part 1.
Cavazzana-Calvo M; Fischer A; Hacein-Bey-Abina S; Aiuti A
Curr Opin Immunol; 2012 Oct; 24(5):580-4. PubMed ID: 22981681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
